“…Current cancer therapeutic options such as chemotherapy, radiation, surgical intervention, and their combinations are extremely limited treatments with low efficiency, multiple drug resistance (MDR), and unbearable adverse side effects . The existing chemotherapeutic drugs, including bleomycin, doxorubicin, etoposide, cisplatin, paclitaxel, docetaxel, and methotrexate, usually trigger cancer cell death via interfering with DNA replication, mitosis, and cell division . In a single chemotherapy, there is less accessibility for the drug to reach tumor sites and high-dosage administration induces severe damage to healthy normal cells .…”